FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Ulf de Faire

Research Profile

Geographic Areas

Sweden

Concepts & Ideas

Disorders

Procedures

Case Control Studies

Chemicals & Drugs

Activities & Behaviors

Smoking

Physiology

Genetic Predisposition to Disease

Co-author Network

Publications

TOP 3
Maria Nastase Mannila; Ann-Christine Syvänen; Ulf de Faire; Gösta Eggertsen; Per Eriksson; Anders Franco-Cereceda; Anders Hamsten; Hovsep Mahdessian; FM van 't Hooft
Identification of a functional apolipoprotein e promoter polymorphism regulating plasma apolipoprotein e concentration.
Sonia Shah; Rona J Strawbridge; Daniel I Swerdlow; Philippa J Talmud; Elena Tremoli; Fabrizio Veglia; Nick Wareham; John Whittaker; Damiano Baldassarre; Juan P Casas; Ulf de Faire; John Deanfield; Fotios Drenos; Karl Gertow; Bruna Gigante; Anders Hamsten; Michael V Holmes; Steve E Humphries; Mika Kivimaki; Meena Kumari; Claudia Langenberg; Bengt Sennblad; Aroon D Hingorani
Causal relevance of blood lipid fractions in the development of carotid atherosclerosis: Mendelian randomization analysis.
Patrik K E Magnusson; Anastasia Nyman; Nancy L Pedersen; Iffat Rahman; Maria Råstam; Fredrik Ullén; Alexander Viktorin; Hasse Walum; Catarina Almqvist; Henrik Anckarsäter; Sven Cnattingius; Ulf de Faire; Andrea Ganna; Clara H Gumpert; Linda Halldner; Erik Ingelsson; Magnus Johannesson; Lars Klareskog; Niklas Långström; Henrik Larsson; Sebastian Lundström; Paul Lichtenstein
The Swedish Twin Registry: establishment of a biobank and other recent developments.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Ulf de Faire (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Maria Nastase Mannila; Ann-Christine Syvänen; Ulf de Faire; Gösta Eggertsen; Per Eriksson; Anders Franco-Cereceda; Anders Hamsten; Hovsep Mahdessian; FM van 't Hooft
Identification of a functional apolipoprotein e promoter polymorphism regulating plasma apolipoprotein e concentration.
Arteriosclerosis, thrombosis, and vascular biology 2013;33(5):1063-9.
2013: Sonia Shah; Rona J Strawbridge; Daniel I Swerdlow; Philippa J Talmud; Elena Tremoli; Fabrizio Veglia; Nick Wareham; John Whittaker; Damiano Baldassarre; Juan P Casas; Ulf de Faire; John Deanfield; Fotios Drenos; Karl Gertow; Bruna Gigante; Anders Hamsten; Michael V Holmes; Steve E Humphries; Mika Kivimaki; Meena Kumari; Claudia Langenberg; Bengt Sennblad; Aroon D Hingorani
Causal relevance of blood lipid fractions in the development of carotid atherosclerosis: Mendelian randomization analysis.
Circulation. Cardiovascular genetics 2013;6(1):63-72.
2013: Patrik K E Magnusson; Anastasia Nyman; Nancy L Pedersen; Iffat Rahman; Maria Råstam; Fredrik Ullén; Alexander Viktorin; Hasse Walum; Catarina Almqvist; Henrik Anckarsäter; Sven Cnattingius; Ulf de Faire; Andrea Ganna; Clara H Gumpert; Linda Halldner; Erik Ingelsson; Magnus Johannesson; Lars Klareskog; Niklas Långström; Henrik Larsson; Sebastian Lundström; Paul Lichtenstein
The Swedish Twin Registry: establishment of a biobank and other recent developments.
Twin research and human genetics : the official journal of the International Society for Twin Studies 2013;16(1):317-29.
2013: Dong Yang; Lars Alfredsson; Ulf de Faire; Stefan James; Tomas Jernberg; Tahereh Moradi
Likelihood of treatment in a coronary care unit for a first-time myocardial infarction in relation to sex, country of birth and socioeconomic position in sweden.
PloS one 2013;8(4):e62316.
2013: Cecilia Wikner; Ulf de Faire; Bruna Gigante; Mai-Lis Hellénius; Karin Leander
The risk of type 2 diabetes in men is synergistically affected by parental history of diabetes and overweight.
PloS one 2013;8(4):e61763.
2013: Jun Su; Max Vikström; Ulf de Faire; Bruna Gigante; Mai-Lis Hellenius; Xiang Hua; Karin Leander; Johan Frostegård
Low levels of IgM antibodies to oxidized cardiolipin increase and high levels decrease risk of cardiovascular disease among 60-year olds: a prospective study.
BMC cardiovascular disorders 2013;13():1.
2012: Sara Ekberg; Nancy L Pedersen; Alexander Ploner; Ulf de Faire; Anna M Bennet
Familial effects on survival after myocardial infarction: a registry-based sib-pair study.
European journal of epidemiology 2012;27(12):911-4.
2012: Dong Yang; Lars Alfredsson; Omid Beiki; Ulf de Faire; Dashti Ali M Dzayee; Tahereh Moradi
Incidence and case fatality after day 28 of first time myocardial infarction in Sweden 1987-2008.
European journal of preventive cardiology 2012;19(6):1304-15.
2012: Damiano Baldassarre; Ulf de Faire; Philippe Giral; Enzo Grossi; Anders Hamsten; Steve E Humphries; Sudhir Kurl; Elmo Mannarino; Rodolfo Paoletti; Rainer Rauramaa; Andries J Smit; Elena Tremoli; Fabrizio Veglia
Measurements of carotid intima-media thickness and of interadventitia common carotid diameter improve prediction of cardiovascular events: results of the IMPROVE (Carotid Intima Media Thickness [IMT] and IMT-Progression as Predictors of Vascular Events in a High Risk European Population) study.
Journal of the American College of Cardiology 2012;60(16):1489-99.
2012: Bruna Gigante; Karin Leander; Max Vikstrom; Matteo Bottai; Axel C Carlsson; Paolo Frumento; Ulf de Faire
Elevated ApoB serum levels strongly predict early cardiovascular events.
Heart (British Cardiac Society) 2012;98(16):1242-5.
2012: Angela Silveira; Barry Woodhams; Susanna Boquist; Ulf de Faire; Carl-Göran Ericsson; Mai-Lis Hellénius; Karin Leander; James H Morrissey; John Ohrvik; Daniela Scanavini; Anders Hamsten
Relationships of plasma factor VIIa-antithrombin complexes to manifest and future cardiovascular disease.
Thrombosis research 2012;130(2):221-5.
2012: Sofia Ajeganova; Ulf de Faire; Johan Frostegård; Tomas Jogestrand; Ingiäld Hafström
Carotid atherosclerosis, disease measures, oxidized low-density lipoproteins, and atheroprotective natural antibodies for cardiovascular disease in early rheumatoid arthritis -- an inception cohort study.
The Journal of rheumatology 2012;39(6):1146-54.
2012: Ekaterina Chernogubova; Ulf de Faire; Per Eriksson; Anders Franco-Cereceda; Bruna Gigante; Anders Hamsten; Mai-Lis Hellénius; Robert J Konrad; Sergey Krapivner; Hovsep Mahdessian; Anders Mälarstig; Rona Strawbridge; Ann-Christine Syvänen; Jason S Troutt; FM van 't Hooft
Common and low-frequency genetic variants in the PCSK9 locus influence circulating PCSK9 levels.
Arteriosclerosis, thrombosis, and vascular biology 2012;32(6):1526-34.
2012: Mats Halldin; Ulf de Faire; Per Fahlstadius; Max Vikström; Mai-Lis Hellénius
The metabolic syndrome and left ventricular hypertrophy--the influence of gender and physical activity.
Blood pressure 2012;21(3):153-60.
2012: Andrea Ganna; Patrik Magnusson; Nancy Pedersen; Marie Reilly; Ulf de Faire; Erik Ingelsson
Risk prediction measures for case-cohort and nested case-control designs: an application to cardiovascular disease.
American journal of epidemiology 2012;175(7):715-24.
2012: Bruna Gigante; Karin Leander; Max Vikström; Shu Ye; Ulf de Faire
Chromosome 1p13 genetic variants antagonize the risk of myocardial infarction associated with high ApoB serum levels.
BMC cardiovascular disorders 2012;12():90.
2011: Iffat Rahman; Ewa Ninio; Nancy L Pedersen; Rajai Atout; Anna M Bennet; Ulf de Faire; Johan Frostegård; Patrik K E Magnusson
Genetic and environmental regulation of inflammatory CVD biomarkers Lp-PLA2 and IgM anti-PC.
Atherosclerosis 2011;218(1):117-22.
2011: Laura Calabresi; Samuela Castelnuovo; Ulf de Faire; Guido Franceschini; Beatrice Frigerio; Philippe Giral; Monica Gomaraschi; Anders Hamsten; Steve E Humphries; Jussi Kauhanen; Elmo Mannarino; Rainer Rauramaa; Alessio Ravani; Daniela Sansaro; Sara Simonelli; Cesare R Sirtori; Andries J Smit; Mauro Amato; Damiano Baldassarre; Fabrizio Veglia; Elena Tremoli
Plasma lecithin:cholesterol acyltransferase and carotid intima-media thickness in European individuals at high cardiovascular risk.
Journal of lipid research 2011;52(8):1569-74.
2011: Nino Künzli; Laura Perez; Stephanie von Klot; Damiano Baldassarre; Marcus Bauer; Xavier Basagana; Carrie Breton; Julia Dratva; Roberto Elosua; Ulf de Faire; Kateryna Fuks; Eric de Groot; Jaume Marrugat; Johanna Penell; Jochen Seissler; Annette Peters; Barbara Hoffmann
Investigating air pollution and atherosclerosis in humans: concepts and outlook.
Progress in cardiovascular diseases 2011;53(5):334-43.
2011: Per E Wändell; A C Carlsson; Ulf de Faire; Mai-Lis B Hellénius
Prevalence of blood lipid disturbances in Swedish and foreign-born 60-year-old men and women in Stockholm, Sweden.
Nutrition, metabolism, and cardiovascular diseases : NMCD 2011;21(3):173-81.
2011: Sofia Carlsson; Tomas Andersson; Ulf de Faire; Paul Lichtenstein; Karl Michaëlsson; Anders Ahlbom
Body mass index and mortality: is the association explained by genetic factors?
Epidemiology (Cambridge, Mass.) 2011;22(1):98-103.
2010: Bob Olsson; Bruna Gigante; Kirsten Mehlig; Alicia Bergsten; Karin Leander; Ulf de Faire; Lauren Lissner; Dag Steinar Thelle; Lena Carlsson
Apolipoprotein C-I genotype and serum levels of triglycerides, C-reactive protein and coronary heart disease.
Metabolism: clinical and experimental 2010;59(12):1736-41.
2010: Miikka Korja; Karri Silventoinen; Peter McCarron; Slobodan Zdravkovic; Axel Skytthe; Arto Haapanen; Ulf de Faire; Nancy L Pedersen; Kaare Christensen; Markku Koskenvuo; Jaakko Kaprio
Genetic epidemiology of spontaneous subarachnoid hemorrhage: Nordic Twin Study.
Stroke; a journal of cerebral circulation 2010;41(11):2458-62.
2010: Menno Vergeer; S Matthijs Boekholdt; Manjinder S Sandhu; Sally L Ricketts; Nicholas J Wareham; Morris J Brown; Ulf de Faire; Karin Leander; Bruna Gigante; Maryam Kavousi; Albert Hofman; Andre G Uitterlinden; Cornelia M van Duijn; Jacqueline C M Witteman; J Wouter Jukema; Eric E Schadt; Ellen van der Schoot; John J P Kastelein; Kay-Tee Khaw; Robin P F Dullaart; Arie Van Tol; Mieke D Trip; Geesje M Dallinga-Thie
Genetic variation at the phospholipid transfer protein locus affects its activity and high-density lipoprotein size and is a novel marker of cardiovascular disease susceptibility.
Circulation 2010;122(5):470-7.
2010: Roland Fiskesund; Birgitta Stegmayr; Göran Hallmans; Max Vikström; Lars Weinehall; Ulf de Faire; Johan Frostegård
Low levels of antibodies against phosphorylcholine predict development of stroke in a population-based study from northern Sweden.
Stroke; a journal of cerebral circulation 2010;41(4):607-12.
2010: Damiano Baldassarre; Kristiina Nyyssönen; Rainer Rauramaa; Ulf de Faire; Anders Hamsten; Andries J Smit; Elmo Mannarino; Steve E Humphries; Philippe Giral; Enzo Grossi; Fabrizio Veglia; Rodolfo Paoletti; Elena Tremoli
Cross-sectional analysis of baseline data to identify the major determinants of carotid intima-media thickness in a European population: the IMPROVE study.
European heart journal 2010;31(5):614-22.
2010: Ulf de Faire; Jun Su; Xiang Hua; Anna Frostegård; Mats Halldin; Mai-Lis Hellenius; Max Wikström; Ingrid Dahlbom; Hans Grönlund; Johan Frostegård
Low levels of IgM antibodies to phosphorylcholine predict cardiovascular disease in 60-year old men: effects on uptake of oxidized LDL in macrophages as a potential mechanism.
Journal of autoimmunity 2010;34(2):73-9.
2010: Børge G Nordestgaard; Kimmo Kontula; Marianne Benn; Björn Dahlöf; Ulf de Faire; Jonathan M Edelman; Erik Eliasson; Frej Fyhrquist; Darcy A Hille; Hans Ibsen; Paulette A Lyle; Kåre Berg; Mia Sandberg; Amar A Sethi; Peggy H Wong; Ingrid Os
Effect of ACE insertion/deletion and 12 other polymorphisms on clinical outcomes and response to treatment in the LIFE study.
Pharmacogenetics and genomics 2010;20(2):77-85.
2010: Cristina Anania; Gustafsson Thomas; Xiang Hua; Jun Su; Max Vikström; Ulf de Faire; Mikael Heimbürger; Tomas Jogestrand; Johan Frostegård
Increased prevalence of vulnerable atherosclerotic plaques and low levels of natural IgM antibodies against phosphorylcholine in patients with systemic lupus erythematosus.
Arthritis research & therapy 2010;12(6):R214.
2010: Ulf Risérus; Ulf de Faire; Lars Berglund; M-L Hellénius
Sagittal abdominal diameter as a screening tool in clinical research: cutoffs for cardiometabolic risk.
Journal of obesity 2010;2010():.
2010: Bruna Gigante; Anna M Bennet; Karin Leander; Max Vikström; Ulf de Faire
The interaction between coagulation factor 2 receptor and interleukin 6 haplotypes increases the risk of myocardial infarction in men.
PloS one 2010;5(6):e11300.
2010: Ulrika K Eriksson; Beatrice G Sjöberg; Anna M Bennet; Ulf de Faire; Nancy L Pedersen; Johan Frostegård
Low levels of antibodies against phosphorylcholine in Alzheimer's disease.
Journal of Alzheimer's disease : JAD 2010;21(2):577-84.
2009: Robert Clarke; John F Peden; Jemma C Hopewell; Theodosios Kyriakou; Anuj Goel; Simon C Heath; Sarah Parish; Simona Barlera; Maria Grazia Franzosi; Stephan Rust; Derrick Bennett; Angela Silveira; Anders Malarstig; Fiona R Green; Mark Lathrop; Bruna Gigante; Karin Leander; Ulf de Faire; Udo Seedorf; Anders Hamsten; Rory Collins; Hugh Watkins; Martin Farrall
Genetic variants associated with Lp(a) lipoprotein level and coronary disease.
The New England journal of medicine 2009;361(26):2518-28.
2009: Sara Hägg; Josefin Skogsberg; Jesper Lundström; Peri Noori; Roland Nilsson; Hua Zhong; Shohreh Maleki; Ming-Mei Shang; Björn Brinne; Maria Bradshaw; Vladimir Bajic; Ann Samnegård; Angela Silveira; Lee M Kaplan; Bruna Gigante; Karin Leander; Ulf de Faire; Stefan Rosfors; Ulf Lockowandt; Jan Liska; Peter Konrad; Rabbe Takolander; Anders Franco-Cereceda; Eric E Schadt; Torbjörn Ivert; Anders Hamsten; Jesper Tegnér; Johan Björkegren
Multi-organ expression profiling uncovers a gene module in coronary artery disease involving transendothelial migration of leukocytes and LIM domain binding 2: the Stockholm Atherosclerosis Gene Expression (STAGE) study.
PLoS genetics 2009;5(12):e1000754.
2009: S Panasevich; Karin Leander; Mats Rosenlund; Petter Ljungman; tom bellander; Ulf de Faire; Göran Pershagen; Fred Nyberg
Associations of long- and short-term air pollution exposure with markers of inflammation and coagulation in a population sample.
Occupational and environmental medicine 2009;66(11):747-53.
2009: Ulf de Faire; Johan Frostegård
Natural antibodies against phosphorylcholine in cardiovascular disease.
Annals of the New York Academy of Sciences 2009;1173():292-300.
2009: Lorelei A Mucci; Chung-Cheng Hsieh; Paige L Williams; Manish Arora; Hans-Olov Adami; Ulf de Faire; Chester W Douglass; Nancy L Pedersen
Do genetic factors explain the association between poor oral health and cardiovascular disease? A prospective study among Swedish twins.
American journal of epidemiology 2009;170(5):615-21.
2009: Axel C Carlsson; Per E Wändell; Gunilla Journath; Ulf de Faire; Mai-Lis Hellénius
Factors associated with uncontrolled hypertension and cardiovascular risk in hypertensive 60-year-old men and women--a population-based study.
Hypertension research : official journal of the Japanese Society of Hypertension 2009;32(9):780-5.
2009: Elena Zotova; Louise Lyrenäs; Ulf de Faire; Ralf Morgenstern; Bruna Gigante; Anna M Bennet
The myeloperoxidase gene and its influence on myocardial infarction in a Swedish population: protective role of the -129A allele in women.
Coronary artery disease 2009;20(5):322-6.
2009: Iffat Rahman; Anna M Bennet; Nancy L Pedersen; Ulf de Faire; Per Svensson; Patrik K E Magnusson
Genetic dominance influences blood biomarker levels in a sample of 12,000 Swedish elderly twins.
Twin research and human genetics : the official journal of the International Society for Twin Studies 2009;12(3):286-94.
2009: Hans Grönlund; Göran Hallmans; Jan-Håkan Jansson; Kurt Boman; Max Wikström; Ulf de Faire; Johan Frostegård
Low levels of IgM antibodies against phosphorylcholine predict development of acute myocardial infarction in a population-based cohort from northern Sweden.
European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology 2009;16(3):382-6.
2009: Axel C Carlsson; Per E Wändell; Mats Halldin; Ulf de Faire; Mai-Lis Hellénius
Is a unified definition of metabolic syndrome needed? Comparison of three definitions of metabolic syndrome in 60-year-old men and women.
Metabolic syndrome and related disorders 2009;7(3):231-41.
2009: Bahman Y Farahmand; G Broman; Ulf de Faire; Denny Vågerö; Anders Ahlbom
Golf: a game of life and death--reduced mortality in Swedish golf players.
Scandinavian journal of medicine & science in sports 2009;19(3):419-24.
2009: Bruna Gigante; Max Vikström; Linda Strömqvist Meuzelaar; Ekaterina Chernogubova; Angela Silveira; Ferdinand Van't Hooft; Anders Hamsten; Ulf de Faire
Variants in the coagulation factor 2 receptor (F2R) gene influence the risk of myocardial infarction in men through an interaction with interleukin 6 serum levels.
Thrombosis and haemostasis 2009;101(5):943-53.
2009: Beatrice G Sjöberg; Jun Su; Ingrid Dahlbom; Hans Grönlund; Max Wikström; Bo Hedblad; Göran Berglund; Ulf de Faire; Johan Frostegård
Low levels of IgM antibodies against phosphorylcholine-A potential risk marker for ischemic stroke in men.
Atherosclerosis 2009;203(2):528-32.
2009: Michael H Olsen; Kristian Wachtell; Gareth Beevers; Björn Dahlöf; Giovanni de Simone; Richard B Devereux; Ulf de Faire; Frej Fyhrquist; Hans Ibsen; Sverre E Kjeldsen; Ole Lederballe-Pedersen; Lars H Lindholm; Paulette A Lyle; Markku S Nieminen; Per Omvik; Suzanne Oparil; Hans Wedel
Effects of losartan compared with atenolol on lipids in patients with hypertension and left ventricular hypertrophy: the Losartan Intervention For Endpoint reduction in hypertension study.
Journal of hypertension 2009;27(3):567-74.
2009: Sverre E Kjeldsen; Richard B Devereux; Darcy A Hille; Paulette A Lyle; Björn Dahlöf; Stevo Julius; Jonathan M Edelman; Steven M Snapinn; Ulf de Faire; Frej Fyhrquist; Hans Ibsen; Ole Lederballe-Pedersen; Lars H Lindholm; Markku S Nieminen; Per Omvik; Suzanne Oparil; Hans Wedel
Predictors of cardiovascular events in patients with hypertension and left ventricular hypertrophy: the Losartan Intervention for Endpoint reduction in hypertension study.
Blood pressure 2009;18(6):348-61.
2009: Eva Warensjö; Magdalena Rosell; Mai-Lis Hellenius; Bengt Vessby; Ulf de Faire; Ulf Risérus
Associations between estimated fatty acid desaturase activities in serum lipids and adipose tissue in humans: links to obesity and insulin resistance.
Lipids in health and disease 2009;8():37.
2009: Beatriz Y Salazar Vázquez; Miguel A Salazar Vázquez; Marcos Intaglietta; Ulf de Faire; Bengt Fagrell; Pedro Cabrales
Hematocrit and mean arterial blood pressure in pre- and postmenopause women.
Vascular health and risk management 2009;5(2):483-8.
2008: Axel C Carlsson; Per E Wändell; Ulf de Faire; Mai-Lis Hellénius
Prevalence of hypertension in immigrants and Swedish-born individuals, a cross-sectional study of 60-year-old men and women in Sweden.
Journal of hypertension 2008;26(12):2295-302.
2008: Gurdeep S Sagoo; Iain Tatt; Georgia Salanti; Adam S Butterworth; Nadeem Sarwar; Merel van Maarle; J Wouter Jukema; Björn Wiman; John J P Kastelein; Anna M Bennet; Ulf de Faire; John Danesh; Julian P T Higgins
Seven lipoprotein lipase gene polymorphisms, lipid fractions, and coronary disease: a HuGE association review and meta-analysis.
American journal of epidemiology 2008;168(11):1233-46.
2008: E Svenungsson; A Cederholm; K Jensen-Urstad; G-Z Fei; Ulf de Faire; Johan Frostegård
Endothelial function and markers of endothelial activation in relation to cardiovascular disease in systemic lupus erythematosus.
Scandinavian journal of rheumatology 2008;37(5):352-9.
2008: Per E Wändell; Sven-Erik Johansson; Catharina Gåfvels; Mai-Lis B Hellénius; Ulf de Faire; Jan Sundquist
Estimation of diabetes prevalence among immigrants from the Middle East in Sweden by using three different data sources.
Diabetes & metabolism 2008;34(4 Pt 1):328-33.
2008: Patrik K E Magnusson; Marcus Boman; Ulf de Faire; Markus Perola; Leena Peltonen; Nancy L Pedersen
Genome-wide search for QTLs for apolipoprotein A-I level in elderly Swedish DZ twins: evidence of female-specific locus on 15q11-13.
European journal of human genetics : EJHG 2008;16(9):1103-10.
2008: Mun-Gwan Hong; Chandra Reynolds; Margaret Gatz; Boo Johansson; Jennifer C Palmer; Harvest F Gu; Kaj Blennow; Pat Kehoe; Ulf de Faire; Nancy L Pedersen; Jonathan A Prince
Evidence that the gene encoding insulin degrading enzyme influences human lifespan.
Human molecular genetics 2008;17(15):2370-8.
2008: J Arpegård; J Ostergren; Ulf de Faire; Lars-Olof Hansson; P Svensson
Cystatin C--a marker of peripheral atherosclerotic disease?
Atherosclerosis 2008;199(2):397-401.
2008: Axel C Carlsson; Per E Wändell; Ulf de Faire; Mai-Lis Hellénius
Risk factors associated with newly diagnosed high blood pressure in men and women.
American journal of hypertension 2008;21(7):771-7.
2008: Justo Sierra-Johnson; Anna-Lena Undén; Madeleine Linestrand; Magdalena Rosell; Per Sjogren; Maria Kolak; Ulf de Faire; Rachel M Fisher; Mai-Lis Hellénius
Eating meals irregularly: a novel environmental risk factor for the metabolic syndrome.
Obesity (Silver Spring, Md.) 2008;16(6):1302-7.
2008: Ulf de Faire
Does parental premature cardiovascular disease predict arterial calcification in offspring?
Nature clinical practice. Cardiovascular medicine 2008;5(5):256-7.
2008: Per Sjögren; Gunilla N Fredrikson; Magdalena S Rosell; Ulf de Faire; Anders Hamsten; Jan Nilsson; Mai-Lis Hellenius; Rachel M Fisher
Autoantibodies against modified apolipoprotein B-100 in relation to low-density lipoprotein size and the metabolic syndrome in otherwise healthy men.
Metabolism: clinical and experimental 2008;57(3):362-6.
2008: Per Sjögren; Justo Sierra-Johnson; Karl Gertow; Magdalena Rosell; Bengt Vessby; Ulf de Faire; Anders Hamsten; Mai-Lis Hellenius; Rachel M Fisher
Fatty acid desaturases in human adipose tissue: relationships between gene expression, desaturation indexes and insulin resistance.
Diabetologia 2008;51(2):328-35.
2008: Per E Wändell; Gunilla Bolinder; Ulf de Faire; Mai-Lis Hellénius
Association between metabolic effects and tobacco use in 60-year-old Swedish men.
European journal of epidemiology 2008;23(6):431-4.
2008: Susanna Boquist; Giacomo Ruotolo; Camilla Skoglund-Andersson; Rong Tang; Johan Björkegren; M Gene Bond; Ulf de Faire; Kerstin Brismar; Anders Hamsten
Correlation of serum IGF-I and IGFBP-1 and -3 to cardiovascular risk indicators and early carotid atherosclerosis in healthy middle-aged men.
Clinical endocrinology 2008;68(1):51-8.
2007: Slobodan Zdravkovic; Andreas Wienke; Nancy L Pedersen; Ulf de Faire
Genetic susceptibility of myocardial infarction.
Twin research and human genetics : the official journal of the International Society for Twin Studies 2007;10(6):848-52.
2007: Per Sjögren; Giuseppina Basta; Raffaele De Caterina; Magdalena Rosell; Samar Basu; Angela Silveira; Ulf de Faire; Bengt Vessby; Anders Hamsten; Mai-Lis Hellenius; Rachel M Fisher
Markers of endothelial activity are related to components of the metabolic syndrome, but not to circulating concentrations of the advanced glycation end-product N epsilon-carboxymethyl-lysine in healthy Swedish men.
Atherosclerosis 2007;195(2):e168-75.
2007: Per E Wändell; Ulf de Faire; M-L Hellénius
High intake of alcohol is associated with newly diagnosed diabetes in 60 years old men and women.
Nutrition, metabolism, and cardiovascular diseases : NMCD 2007;17(8):598-608.
2007: Anna M Bennet; Emanuele Di Angelantonio; Zheng Ye; Frances Wensley; Anette Dahlin; Anders Ahlbom; Bernard Keavney; Rory Collins; Björn Wiman; Ulf de Faire; John Danesh
Association of apolipoprotein E genotypes with lipid levels and coronary risk.
JAMA : the journal of the American Medical Association 2007;298(11):1300-11.
2007: Karin Leander; Björn Wiman; Johan Hallqvist; Tomas Andersson; Anders Ahlbom; Ulf de Faire
Primary risk factors influence risk of recurrent myocardial infarction/death from coronary heart disease: results from the Stockholm Heart Epidemiology Program (SHEEP).
European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology 2007;14(4):532-7.
2007: Slobodan Zdravkovic; Andreas Wienke; Nancy L Pedersen; Ulf de Faire
Genetic influences on angina pectoris and its impact on coronary heart disease.
European journal of human genetics : EJHG 2007;15(8):872-7.
2007: Niklas Bergvall; Anastasia Iliadou; Stefan Johansson; Ulf de Faire; Michael S Kramer; Yudi Pawitan; Nancy L Pedersen; Paul Lichtenstein; Sven Cnattingius
Genetic and shared environmental factors do not confound the association between birth weight and hypertension: a study among Swedish twins.
Circulation 2007;115(23):2931-8.
2007: M Halldin; Magdalena S Rosell; Ulf de Faire; Mai-Lis B Hellénius
The metabolic syndrome: prevalence and association to leisure-time and work-related physical activity in 60-year-old men and women.
Nutrition, metabolism, and cardiovascular diseases : NMCD 2007;17(5):349-57.
2007: Mun-Gwan Hong; Anna M Bennet; Ulf de Faire; Jonathan A Prince
Phenotype selection for detecting variable genes: a survey of cardiovascular quantitative traits and TNF locus polymorphism.
European journal of human genetics : EJHG 2007;15(6):685-93.
2007: Bruna Gigante; Alessandro Bellis; Roberta Visconti; Marina Marino; Carmine Morisco; Valentina Trimarco; Gennaro Galasso; Federico Piscione; Nicola De Luca; Jonathan A Prince; Ulf de Faire; Bruno Trimarco
Retrospective analysis of coagulation factor II receptor (F2R) sequence variation and coronary heart disease in hypertensive patients.
Arteriosclerosis, thrombosis, and vascular biology 2007;27(5):1213-9.
2007: Richard B Devereux; Ulf de Faire; Frej Fyhrquist; Katherine E Harris; Hans Ibsen; Sverre E Kjeldsen; Ole Lederballe-Pedersen; Lars H Lindholm; Markku S Nieminen; Per Omvik; Suzanne Oparil; Hans Wedel; Darcy A Hille; Björn Dahlöf
Blood pressure reduction and antihypertensive medication use in the losartan intervention for endpoint reduction in hypertension (LIFE) study in patients with hypertension and left ventricular hypertrophy.
Current medical research and opinion 2007;23(2):259-70.
2007: Per E Wändell; A Wajngot; Ulf de Faire; M-L Hellénius
Increased prevalence of diabetes among immigrants from non-European countries in 60-year-old men and women in Sweden.
Diabetes & metabolism 2007;33(1):30-6.
2007: Maria Nastase Mannila; Per Eriksson; Karin Leander; Björn Wiman; Ulf de Faire; Anders Hamsten; Angela Silveira
The association between fibrinogen haplotypes and myocardial infarction in men is partly mediated through pleiotropic effects on the serum IL-6 concentration.
Journal of internal medicine 2007;261(2):138-47.
2007: Peter Lindgren; Jaana Lindström; Jaakko Tuomilehto; Matti Uusitupa; Markku Peltonen; Bengt Jönsson; Ulf de Faire; Mai-Lis Hellénius
Lifestyle intervention to prevent diabetes in men and women with impaired glucose tolerance is cost-effective.
International journal of technology assessment in health care 2007;23(2):177-83.
2007: Per Svensson; Ulf de Faire; Urban Niklasson; Jan Ostergren
Myocardial ischaemia in patients with peripheral arterial disease.
Clinical physiology and functional imaging 2007;27(1):30-5.
2006: Paul Lichtenstein; Patrick F Sullivan; Sven Cnattingius; Margaret Gatz; Sofie Johansson; Eva Carlström; Camilla Björk; Magnus Svartengren; Alicja Wolk; Lars Klareskog; Ulf de Faire; Martin Schalling; Juni Palmgren; Nancy L Pedersen
The Swedish Twin Registry in the third millennium: an update.
Twin research and human genetics : the official journal of the International Society for Twin Studies 2006;9(6):875-82.
2006: Karl Gertow; Magdalena Rosell; Per Sjögren; Per Eriksson; Bengt Vessby; Ulf de Faire; Anders Hamsten; Mai-Lis Hellenius; Rachel M Fisher
Fatty acid handling protein expression in adipose tissue, fatty acid composition of adipose tissue and serum, and markers of insulin resistance.
European journal of clinical nutrition 2006;60(12):1406-13.
2006: Anna M Bennet; Marta E Alarcón-Riquelme; Björn Wiman; Ulf de Faire; Ludmila Prokunina-Olsson
Decreased risk for myocardial infarction and lower tumor necrosis factor-alpha levels in carriers of variants of the PDCD1 gene.
Human immunology 2006;67(9):700-5.
2006: Jun Su; Anastasia Georgiades; Ruihua Wu; Thomas Thulin; Ulf de Faire; Johan Frostegård
Antibodies of IgM subclass to phosphorylcholine and oxidized LDL are protective factors for atherosclerosis in patients with hypertension.
Atherosclerosis 2006;188(1):160-6.
2006: Anna M Bennet; M C van Maarle; J Hallqvist; Ralf Morgenstern; Johan Frostegård; Björn Wiman; Jonathan A Prince; Ulf de Faire
Association of TNF-alpha serum levels and TNFA promoter polymorphisms with risk of myocardial infarction.
Atherosclerosis 2006;187(2):408-14.
2006: Karri Silventoinen; Slobodan Zdravkovic; Axel Skytthe; Peter McCarron; Anne Maria Herskind; Markku Koskenvuo; Ulf de Faire; Nancy Pedersen; Kaare Christensen; Jaakko Kaprio
Association between height and coronary heart disease mortality: a prospective study of 35,000 twin pairs.
American journal of epidemiology 2006;163(7):615-21.
2006: Eleonor Fransson; Ulf de Faire; Anders Ahlbom; Christina Reuterwall; Johan Hallqvist; Lars Alfredsson
The effect of leisure-time physical activity on the risk of acute myocardial infarction depending on body mass index: a population-based case-control study.
BMC public health 2006;6():296.
2006: Hagit Katzov; Anna M Bennet; Kina Höglund; Björn Wiman; Dieter Lütjohann; Anthony J Brookes; Niels Andreasen; Kaj Blennow; Ulf de Faire; Jonathan A Prince
Quantitative trait loci in ABCA1 modify cerebrospinal fluid amyloid-beta 1-42 and plasma apolipoprotein levels.
Journal of human genetics 2006;51(3):171-9.
2005: Per Sjogren; Samar Basu; Magdalena Rosell; Angela Silveira; Ulf de Faire; Bengt Vessby; Anders Hamsten; Mai-Lis Hellenius; Rachel M Fisher
Measures of oxidized low-density lipoprotein and oxidative stress are not related and not elevated in otherwise healthy men with the metabolic syndrome.
Arteriosclerosis, thrombosis, and vascular biology 2005;25(12):2580-6.
2005: Sverre E Kjeldsen; Paulette A Lyle; Andrew M Tershakovec; Richard B Devereux; Suzanne Oparil; Björn Dahlöf; Ulf de Faire; Frej Fyhrquist; Hans Ibsen; Krister Kristianson; Ole Lederballe-Pedersen; Lars H Lindholm; Markku S Nieminen; Per Omvik; Hans Wedel
Targeting the renin-angiotensin system for the reduction of cardiovascular outcomes in hypertension: angiotensin-converting enzyme inhibitors and angiotensin receptor blockers.
Expert opinion on emerging drugs 2005;10(4):729-45.
2005: Eigil Fossum; andreas moan; Sverre E Kjeldsen; Richard B Devereux; Stevo Julius; Steven M Snapinn; Jonathan Edelman; Ulf de Faire; Frej Fyhrquist; Hans Ibsen; Krister Kristianson; Ole Lederballe-Pedersen; Lars H Lindholm; Markku S Nieminen; Per Omvik; Suzanne Oparil; Hans Wedel; Björn Dahlöf
The effect of losartan versus atenolol on cardiovascular morbidity and mortality in patients with hypertension taking aspirin: the Losartan Intervention for Endpoint Reduction in hypertension (LIFE) study.
Journal of the American College of Cardiology 2005;46(5):770-5.
2005: Johnny Steuer; Fredrik Granath; Ulf de Faire; Anders Ekbom; Elisabeth Ståhle
Increased risk of heart failure as a consequence of perioperative myocardial injury after coronary artery bypass grafting.
Heart (British Cardiac Society) 2005;91(6):754-8.
2005: Giovanni de Simone; Kristian Wachtell; Vittorio Palmieri; Darcy A Hille; Gareth Beevers; Björn Dahlöf; Ulf de Faire; Frej Fyhrquist; Hans Ibsen; Stevo Julius; Sverre E Kjeldsen; Ole Lederballe-Pedersen; Lars H Lindholm; Markku S Nieminen; Per Omvik; Suzanne Oparil; Richard B Devereux
Body build and risk of cardiovascular events in hypertension and left ventricular hypertrophy: the LIFE (Losartan Intervention For Endpoint reduction in hypertension) study.
Circulation 2005;111(15):1924-31.
2005: Anders Hamsten; Angela Silveira; Susanna Boquist; Rong Tang; M Gene Bond; Ulf de Faire; Johan Björkegren
The apolipoprotein CI content of triglyceride-rich lipoproteins independently predicts early atherosclerosis in healthy middle-aged men.
Journal of the American College of Cardiology 2005;45(7):1013-7.
2005: Frej Fyhrquist; Björn Dahlöf; Richard B Devereux; Sverre E Kjeldsen; Stevo Julius; Gareth Beevers; Ulf de Faire; Hans Ibsen; Krister Kristianson; Ole Lederballe-Pedersen; Lars H Lindholm; Markku S Nieminen; Per Omvik; Suzanne Oparil; Darcy A Hille; Paulette A Lyle; Jonathan Edelman; Steven M Snapinn; Hans Wedel
Pulse pressure and effects of losartan or atenolol in patients with hypertension and left ventricular hypertrophy.
Hypertension 2005;45(4):580-5.
2005: Xiaosong Wang; Massimiliano Ria; Peter M Kelmenson; Per Eriksson; David C Higgins; Ann Samnegård; Christina Petros; Jarod Rollins; Anna M Bennet; Björn Wiman; Ulf de Faire; Charlotte Wennberg; Per Olsson; Naoto Ishii; Kazuo Sugamura; Anders Hamsten; Kristina Forsman-Semb; Jacob Lagercrantz; Beverly Paigen
Positional identification of TNFSF4, encoding OX40 ligand, as a gene that influences atherosclerosis susceptibility.
Nature genetics 2005;37(4):365-72.
2005: Sverre E Kjeldsen; Paulette A Lyle; Jorge R Kizer; Björn Dahlöf; Richard B Devereux; Stevo Julius; Gareth Beevers; Ulf de Faire; Frej Fyhrquist; Hans Ibsen; Krister Kristianson; Ole Lederballe-Pedersen; Lars H Lindholm; Markku S Nieminen; Per Omvik; Suzanne Oparil; Steven M Snapinn; Katherine E Harris; Hans Wedel
The effects of losartan compared to atenolol on stroke in patients with isolated systolic hypertension and left ventricular hypertrophy. The LIFE study.
Journal of clinical hypertension (Greenwich, Conn.) 2005;7(3):152-8.
2005: Hans Ibsen; Michael H Olsen; Kristian Wachtell; Knut Borch-Johnsen; Lars H Lindholm; Carl Erik Mogensen; Björn Dahlöf; Richard B Devereux; Ulf de Faire; Frej Fyhrquist; Stevo Julius; Sverre E Kjeldsen; Ole Lederballe-Pedersen; Markku S Nieminen; Per Omvik; Suzanne Oparil; Ying Wan
Reduction in albuminuria translates to reduction in cardiovascular events in hypertensive patients: losartan intervention for endpoint reduction in hypertension study.
Hypertension 2005;45(2):198-202.
2005: Erland Linjer; Thomas Hedner; Bengt Jönsson; Tord Ekbom; Lars H Lindholm; Björn Dahlöf; Ulf de Faire; Bengt Scherstén
Cost analysis of different pharmacological treatment strategies in elderly hypertensives.
Blood pressure 2005;14(2):107-13.
2005: Per Svensson; Ulf de Faire; Urban Niklasson; Lars-Olof Hansson; Jan Ostergren
Plasma NT-proBNP concentration is related to ambulatory pulse pressure in peripheral arterial disease.
Blood pressure 2005;14(2):99-106.
2005: Arvid Nordenhem; Karin Leander; Johan Hallqvist; Ulf de Faire; Margareta Sten-Linder; Björn Wiman
The complex between tPA and PAI-1: risk factor for myocardial infarction as studied in the SHEEP project.
Thrombosis research 2005;116(3):223-32.
2005: Magdalena S Rosell; G Johansson; Lars Berglund; B Vessby; Ulf de Faire; Mai-Lis B Hellénius
The relation between alcohol intake and physical activity and the fatty acids 14 : 0, 15 : 0 and 17 : 0 in serum phospholipids and adipose tissue used as markers for dairy fat intake.
The British journal of nutrition 2005;93(1):115-21.
2005: Jette Möller; Töres Theorell; Ulf de Faire; Anders Ahlbom; Johan Hallqvist
Work related stressful life events and the risk of myocardial infarction. Case-control and case-crossover analyses within the Stockholm heart epidemiology programme (SHEEP).
Journal of epidemiology and community health 2005;59(1):23-30.
2005: Jorge R Kizer; Björn Dahlöf; Sverre E Kjeldsen; Stevo Julius; Gareth Beevers; Ulf de Faire; Frej Fyhrquist; Hans Ibsen; Krister Kristianson; Ole Lederballe-Pedersen; Lars H Lindholm; Markku S Nieminen; Per Omvik; Suzanne Oparil; Hans Wedel; Kristian Wachtell; Jonathan Edelman; Steven M Snapinn; Katherine E Harris; Richard B Devereux
Stroke reduction in hypertensive adults with cardiac hypertrophy randomized to losartan versus atenolol: the Losartan Intervention For Endpoint reduction in hypertension study.
Hypertension 2005;45(1):46-52.
2004: Mats Halldin; Paul Hjemdahl; Ulf de Faire; Lars H Lindholm; Ola Samuelsson
[Reply from the SBU about salt and high blood pressure: More controlled long-term trials are required].
Läkartidningen 2004;101(51-52):4257.
2004: Slobodan Zdravkovic; Andreas Wienke; Nancy L Pedersen; Marjorie E Marenberg; Anatoliy Yashin; Ulf de Faire
Genetic influences on CHD-death and the impact of known risk factors: comparison of two frailty models.
Behavior genetics 2004;34(6):585-92.
2004: Hagit Katzov; Anna M Bennet; Pat Kehoe; Björn Wiman; Margaret Gatz; Kaj Blennow; Boris Lenhard; Nancy L Pedersen; Ulf de Faire; Jonathan A Prince
A cladistic model of ACE sequence variation with implications for myocardial infarction, Alzheimer disease and obesity.
Human molecular genetics 2004;13(21):2647-57.
2004: Magdalena S Rosell; G Johansson; Lars Berglund; B Vessby; Ulf de Faire; Mai-Lis B Hellénius
Associations between the intake of dairy fat and calcium and abdominal obesity.
International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity 2004;28(11):1427-34.
2004: Hans Ibsen; Kristian Wachtell; Michael H Olsen; Knut Borch-Johnsen; Lars H Lindholm; Carl Erik Mogensen; Björn Dahlöf; Richard B Devereux; Ulf de Faire; Frej Fyhrquist; Stevo Julius; Sverre E Kjeldsen; Ole Lederballe-Pedersen; Markku S Nieminen; Per Omvik; Suzanne Oparil; Ying Wan
Does albuminuria predict cardiovascular outcome on treatment with losartan versus atenolol in hypertension with left ventricular hypertrophy? A LIFE substudy.
Journal of hypertension 2004;22(9):1805-11.
2004: Eleonor Fransson; Ulf de Faire; Anders Ahlbom; Christina Reuterwall; Johan Hallqvist; Lars Alfredsson
The risk of acute myocardial infarction: interactions of types of physical activity.
Epidemiology (Cambridge, Mass.) 2004;15(5):573-82.
2004: Kristina Edfeldt; Anna M Bennet; Per Eriksson; Johan Frostegård; Björn Wiman; Anders Hamsten; Göran K Hansson; Ulf de Faire; Zhong-qun Yan
Association of hypo-responsive toll-like receptor 4 variants with risk of myocardial infarction.
European heart journal 2004;25(16):1447-53.
2004: Per Sjogren; Magdalena Rosell; Camilla Skoglund-Andersson; Slobodan Zdravkovic; Bengt Vessby; Ulf de Faire; Anders Hamsten; Mai-Lis Hellenius; Rachel M Fisher
Milk-derived fatty acids are associated with a more favorable LDL particle size distribution in healthy men.
The Journal of nutrition 2004;134(7):1729-35.
2004: Ludmila Prokunina-Olsson; Leonid Padyukov; Anna Bennet; Ulf de Faire; Björn Wiman; Jonathan Prince; Lars Alfredsson; Lars Klareskog; Marta E Alarcón-Riquelme
Association of the PD-1.3A allele of the PDCD1 gene in patients with rheumatoid arthritis negative for rheumatoid factor and the shared epitope.
Arthritis and rheumatism 2004;50(6):1770-3.
2004: Erica M Brostedt; Ulf de Faire; Peter Westerholm; Anders Knutsson; Lars Alfredsson
Job strain and plasminogen activator inhibitor-1: results from the Swedish WOLF study.
International archives of occupational and environmental health 2004;77(5):341-4.
2004: Henrik M Reims; Sverre E Kjeldsen; W E Brady; Björn Dahlöf; Richard B Devereux; Stevo Julius; Gareth Beevers; Ulf de Faire; Frej Fyhrquist; Hans Ibsen; Krister Kristianson; Ole Lederballe-Pedersen; Lars H Lindholm; Markku S Nieminen; Per Omvik; Suzanne Oparil; Hans Wedel
Alcohol consumption and cardiovascular risk in hypertensives with left ventricular hypertrophy: the LIFE study.
Journal of human hypertension 2004;18(6):381-9.
2004: Pat Kehoe; Hagit Katzov; Niels Andreasen; Margaret Gatz; Gordon K Wilcock; Nigel J Cairns; Juni Palmgren; Ulf de Faire; Anthony J Brookes; Nancy L Pedersen; Kaj Blennow; Jonathan A Prince
Common variants of ACE contribute to variable age-at-onset of Alzheimer's disease.
Human genetics 2004;114(5):478-83.
2004: Anastasia Georgiades; Ulf de Faire; Carola Lemne
Clinical prediction of normotension in borderline hypertensive men--a 10 year study.
Journal of hypertension 2004;22(3):471-8.
2004: P Svensson; Ulf de Faire; Urban Niklasson; Jan Ostergren
Office blood pressure underestimates ambulatory blood pressure in peripheral arterial disease in comparison to healthy controls.
Journal of human hypertension 2004;18(3):193-200.
2004: Aud Høieggen; Michael H Alderman; Sverre E Kjeldsen; Stevo Julius; Richard B Devereux; Ulf de Faire; Frej Fyhrquist; Hans Ibsen; Krister Kristianson; Ole Lederballe-Pedersen; Lars H Lindholm; Markku S Nieminen; Per Omvik; Suzanne Oparil; Hans Wedel; Cong Chen; Björn Dahlöf
The impact of serum uric acid on cardiovascular outcomes in the LIFE study.
Kidney international 2004;65(3):1041-9.
2004: Ulf de Faire; Jonathan Prince
Genes and environment behind ethnical differences in variations in left ventricular mass.
Journal of hypertension 2004;22(2):241-3.
2004: Henrik M Reims; Suzanne Oparil; Sverre E Kjeldsen; Richard B Devereux; Stevo Julius; William E Brady; Frej Fyhrquist; Hans Ibsen; Lars H Lindholm; Per Omvik; Hans Wedel; Gareth Beevers; Ulf de Faire; Krister Kristianson; Ole Lederballe-Pedersen; Markku S Nieminen; Björn Dahlöf
Losartan benefits over atenolol in non-smoking hypertensive patients with left ventricular hypertrophy: the LIFE study.
Blood pressure 2004;13(6):376-84.
2004: Tord Ekbom; Erland Linjer; Thomas Hedner; Jan Lanke; Ulf de Faire; PO Wester; Björn Dahlöf; Bengt Scherstén
Cardiovascular events in elderly patients with isolated systolic hypertension. A subgroup analysis of treatment strategies in STOP-Hypertension-2.
Blood pressure 2004;13(3):137-41.
2003: Kristian Wachtell; Hans Ibsen; Michael H Olsen; Knut Borch-Johnsen; Lars H Lindholm; Carl Erik Mogensen; Björn Dahlöf; Richard B Devereux; Gareth Beevers; Ulf de Faire; Frej Fyhrquist; Stevo Julius; Sverre E Kjeldsen; Krister Kristianson; Ole Lederballe-Pedersen; Markku S Nieminen; Peter M Okin; Per Omvik; Suzanne Oparil; Hans Wedel; Steven M Snapinn; Peter Aurup
Albuminuria and cardiovascular risk in hypertensive patients with left ventricular hypertrophy: the LIFE study.
Annals of internal medicine 2003;139(11):901-6.
2003: Umit Yasar; Anna M Bennet; Erik Eliasson; Stefan Lundgren; Björn Wiman; Ulf de Faire; Anders Rane
Allelic variants of cytochromes P450 2C modify the risk for acute myocardial infarction.
Pharmacogenetics 2003;13(12):715-20.
2003: Johan Frostegård; Ruihua Wu; Carola Lemne; Thomas Thulin; Joseph L Witztum; Ulf de Faire
Circulating oxidized low-density lipoprotein is increased in hypertension.
Clinical science (London, England : 1979) 2003;105(5):615-20.
2003: A Graham Pockley; Anastasia Georgiades; Thomas Thulin; Ulf de Faire; Johan Frostegård
Serum heat shock protein 70 levels predict the development of atherosclerosis in subjects with established hypertension.
Hypertension 2003;42(3):235-8.
2003: Richard B Devereux; Björn Dahlöf; Sverre E Kjeldsen; Stevo Julius; Peter Aurup; Gareth Beevers; Jonathan Edelman; Ulf de Faire; Frej Fyhrquist; Sigrid Helle Berg; Hans Ibsen; Krister Kristianson; Ole Lederballe-Pedersen; Lars H Lindholm; Markku S Nieminen; Per Omvik; Suzanne Oparil; Steven M Snapinn; Hans Wedel
Effects of losartan or atenolol in hypertensive patients without clinically evident vascular disease: a substudy of the LIFE randomized trial.
Annals of internal medicine 2003;139(3):169-77.
2003: Christina Holmquist; Susanna Larsson; Alicja Wolk; Ulf de Faire
Multivitamin supplements are inversely associated with risk of myocardial infarction in men and women--Stockholm Heart Epidemiology Program (SHEEP).
The Journal of nutrition 2003;133(8):2650-4.
2003: Magdalena S Rosell; Mai-Lis B Hellénius; Ulf de Faire; Gunnar K Johansson
Associations between diet and the metabolic syndrome vary with the validity of dietary intake data.
The American journal of clinical nutrition 2003;78(1):84-90.
2003: Karin Leander; Björn Wiman; Johan Hallqvist; Margareta Sten-Linder; Ulf de Faire
PAI-1 level and the PAI-1 4G/5G polymorphism in relation to risk of non-fatal myocardial infarction: results from the Stockholm Heart Epidemiology Program (SHEEP).
Thrombosis and haemostasis 2003;89(6):1064-71.
2003: Pat Kehoe; Hagit Katzov; Lars Feuk; Anna M Bennet; Boo Johansson; Björn Wiman; Ulf de Faire; Nigel J Cairns; Gordon K Wilcock; Anthony J Brookes; Kaj Blennow; Jonathan A Prince
Haplotypes extending across ACE are associated with Alzheimer's disease.
Human molecular genetics 2003;12(8):859-67.
2003: Peter Lindgren; Per Fahlstadius; Mai-Lis Hellenius; Bengt Jönsson; Ulf de Faire
Cost-effectiveness of primary prevention of coronary heart disease through risk factor intervention in 60-year-old men from the county of Stockholm--a stochastic model of exercise and dietary advice.
Preventive medicine 2003;36(4):403-9.
2003: Deborah Finkel; Nancy L Pedersen; Chandra A Reynolds; Stig Berg; Ulf de Faire; Magnus Svartengren
Genetic and environmental influences on decline in biobehavioral markers of aging.
Behavior genetics 2003;33(2):107-23.
2003: Magdalena S Rosell; Ulf de Faire; Mai-Lis B Hellénius
Low prevalence of the metabolic syndrome in wine drinkers--is it the alcohol beverage or the lifestyle?
European journal of clinical nutrition 2003;57(2):227-34.
2003: Ulf de Faire
Anti-atherosclerotic effects by AT1 receptor blockade.
Journal of hypertension 2003;21(2):259-60.
2003: Eleonor Fransson; Lars Alfredsson; Ulf de Faire; Anders Knutsson; Peter Westerholm
Leisure time, occupational and household physical activity, and risk factors for cardiovascular disease in working men and women: the WOLF study.
Scandinavian journal of public health 2003;31(5):324-33.
2002: Umit Yasar; Stefan Lundgren; Erik Eliasson; Anna Bennet; Björn Wiman; Ulf de Faire; Anders Rane
Linkage between the CYP2C8 and CYP2C9 genetic polymorphisms.
Biochemical and biophysical research communications 2002;299(1):25-8.
2002: Anna M Bennet; Kerstin Brismar; Johan Hallqvist; Christina Reuterwall; Ulf de Faire
The risk of myocardial infarction is enhanced by a synergistic interaction between serum insulin and smoking.
European journal of endocrinology / European Federation of Endocrine Societies 2002;147(5):641-7.
2002: Karin Leander; Björn Wiman; Johan Hallqvist; G Falk; Ulf de Faire
The G-455A polymorphism of the fibrinogen Bbeta-gene relates to plasma fibrinogen in male cases, but does not interact with environmental factors in causing myocardial infarction in either men or women.
Journal of internal medicine 2002;252(4):332-41.
2002: Sverre E Kjeldsen; Björn Dahlöf; Richard B Devereux; Stevo Julius; Peter Aurup; Jonathan Edelman; Gareth Beevers; Ulf de Faire; Frej Fyhrquist; Hans Ibsen; Krister Kristianson; Ole Lederballe-Pedersen; Lars H Lindholm; Markku S Nieminen; Per Omvik; Suzanne Oparil; Steven M Snapinn; Hans Wedel
Effects of losartan on cardiovascular morbidity and mortality in patients with isolated systolic hypertension and left ventricular hypertrophy: a Losartan Intervention for Endpoint Reduction (LIFE) substudy.
JAMA : the journal of the American Medical Association 2002;288(12):1491-8.
2002: Slobodan Zdravkovic; A Wienke; N L Pedersen; Marjorie E Marenberg; Anatoliy Yashin; Ulf de Faire
Heritability of death from coronary heart disease: a 36-year follow-up of 20 966 Swedish twins.
Journal of internal medicine 2002;252(3):247-54.
2002: Paul Lichtenstein; Ulf de Faire; Birgitta Floderus; M Svartengren; Pia Svedberg; Nancy L Pedersen
The Swedish Twin Registry: a unique resource for clinical, epidemiological and genetic studies.
Journal of internal medicine 2002;252(3):184-205.
2002: Johan Björkegren; Angela Silveira; Susanna Boquist; Rong Tang; Fredrik Karpe; M Gene Bond; Ulf de Faire; Anders Hamsten
Postprandial enrichment of remnant lipoproteins with apoC-I in healthy normolipidemic men with early asymptomatic atherosclerosis.
Arteriosclerosis, thrombosis, and vascular biology 2002;22(9):1470-4.
2002: Lars H Lindholm; Hans Ibsen; Knut Borch-Johnsen; Michael H Olsen; Kristian Wachtell; Björn Dahlöf; Richard B Devereux; Gareth Beevers; Ulf de Faire; Frej Fyhrquist; Stevo Julius; Sverre E Kjeldsen; Krister Kristianson; Ole Lederballe-Pedersen; Markku S Nieminen; Per Omvik; Suzanne Oparil; Hans Wedel; Peter Aurup; Jonathan Edelman; Steven M Snapinn
Risk of new-onset diabetes in the Losartan Intervention For Endpoint reduction in hypertension study.
Journal of hypertension 2002;20(9):1879-86.
2002: A Graham Pockley; Ulf de Faire; Rolf Kiessling; Carola Lemne; Thomas Thulin; Johan Frostegård
Circulating heat shock protein and heat shock protein antibody levels in established hypertension.
Journal of hypertension 2002;20(9):1815-20.
2002: Lars Alfredsson; Niklas Hammar; Eleonor Fransson; Ulf de Faire; Johan Hallqvist; Anders Knutsson; Tohr Karl Nilsson; Töres Theorell; Peter Westerholm
Job strain and major risk factors for coronary heart disease among employed males and females in a Swedish study on work, lipids and fibrinogen.
Scandinavian journal of work, environment & health 2002;28(4):238-48.
2002: Anastasia Iliadou; Paul Lichtenstein; Ralf Morgenstern; Lena Forsberg; Richard Svensson; Ulf de Faire; Nicholas G Martin; Nancy L Pedersen
Repeated blood pressure measurements in a sample of Swedish twins: heritabilities and associations with polymorphisms in the renin-angiotensin-aldosterone system.
Journal of hypertension 2002;20(8):1543-50.
2002: Sverre E Kjeldsen; Thomas Hedner; Jan Otto Syvertsen; Per Lund-Johansen; Lennart Hansson; Jan Lanke; Lars H Lindholm; Ulf de Faire; Björn Dahlöf; Bengt E Karlberg
Influence of age, sex and blood pressure on the principal endpoints of the Nordic Diltiazem (NORDIL) Study.
Journal of hypertension 2002;20(6):1231-7.
2002: Ulf de Faire
Adrenoreceptor genes and hypertension: contribution from genetic polymorphisms.
Journal of hypertension 2002;20(6):1047-8.
2002: Johnny Steuer; Paul Blomqvist; Fredrik Granath; Bo Rydh; Anders Ekbom; Ulf de Faire; Elisabeth Ståhle
Hospital readmission after coronary artery bypass grafting: are women doing worse?
The Annals of thoracic surgery 2002;73(5):1380-6.
2002: Lars H Lindholm; Hans Ibsen; Björn Dahlöf; Richard B Devereux; Gareth Beevers; Ulf de Faire; Frej Fyhrquist; Stevo Julius; Sverre E Kjeldsen; Krister Kristiansson; Ole Lederballe-Pedersen; Markku S Nieminen; Per Omvik; Suzanne Oparil; Hans Wedel; Peter Aurup; Jonathan Edelman; Steven M Snapinn
Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol.
Lancet 2002;359(9311):1004-10.
2002: Björn Dahlöf; Richard B Devereux; Sverre E Kjeldsen; Stevo Julius; Gareth Beevers; Ulf de Faire; Frej Fyhrquist; Hans Ibsen; Krister Kristiansson; Ole Lederballe-Pedersen; Lars H Lindholm; Markku S Nieminen; Per Omvik; Suzanne Oparil; Hans Wedel
Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol.
Lancet 2002;359(9311):995-1003.
2002: Tiina Skoog; W Dichtl; Susanna Boquist; Camilla Skoglund-Andersson; Fredrik Karpe; Rong Tang; M Gene Bond; Ulf de Faire; J Nilsson; Per Eriksson; Anders Hamsten
Plasma tumour necrosis factor-alpha and early carotid atherosclerosis in healthy middle-aged men.
European heart journal 2002;23(5):376-83.
2001: Jette Möller; A Ahlbom; J Hulting; Finn Diderichsen; Ulf de Faire; Christina Reuterwall; Johan Hallqvist
Sexual activity as a trigger of myocardial infarction. A case-crossover analysis in the Stockholm Heart Epidemiology Programme (SHEEP).
Heart (British Cardiac Society) 2001;86(4):387-90.
2001: F M van 't Hooft; Giacomo Ruotolo; Susanna Boquist; Ulf de Faire; G Eggertsen; Anders Hamsten
Human evidence that the apolipoprotein a-II gene is implicated in visceral fat accumulation and metabolism of triglyceride-rich lipoproteins.
Circulation 2001;104(11):1223-8.
2001: Lars H Lindholm; H Anderson; Tord Ekbom; Lennart Hansson; Jan Lanke; Björn Dahlöf; Ulf de Faire; K Forsén; Thomas Hedner; Erland Linjer; Bengt Scherstén; PO Wester; Torgil R Möller
Relation between drug treatment and cancer in hypertensives in the Swedish Trial in Old Patients with Hypertension 2: a 5-year, prospective, randomised, controlled trial.
Lancet 2001;358(9281):539-44.
2001: Anastasia Iliadou; Paul Lichtenstein; Ulf de Faire; Nancy L Pedersen
Variation in genetic and environmental influences in serum lipid and apolipoprotein levels across the lifespan in Swedish male and female twins.
American journal of medical genetics 2001;102(1):48-58.
2001: R Rau; Anastasia Georgiades; Mats Fredrikson; Carola Lemne; Ulf de Faire
Psychosocial work characteristics and perceived control in relation to cardiovascular rewind at night.
Journal of occupational health psychology 2001;6(3):171-81.
2001: Anna Hübinette; Sven Cnattingius; Anders Ekbom; Ulf de Faire; M Kramer; Paul Lichtenstein
Birthweight, early environment, and genetics: a study of twins discordant for acute myocardial infarction.
Lancet 2001;357(9273):1997-2001.
2001: Karin Leander; Johan Hallqvist; Christina Reuterwall; Anders Ahlbom; Ulf de Faire
Family history of coronary heart disease, a strong risk factor for myocardial infarction interacting with other cardiovascular risk factors: results from the Stockholm Heart Epidemiology Program (SHEEP).
Epidemiology (Cambridge, Mass.) 2001;12(2):215-21.
2001: A M Bennet; T I Näslund; Ralf Morgenstern; Ulf de Faire
Bioinformatic and experimental tools for identification of single-nucleotide polymorphisms in genes with a potential role for the development of the insulin resistance syndrome.
Journal of internal medicine 2001;249(2):127-36.
2001: Fredrik Karpe; Susanna Boquist; Rong Tang; G M Bond; Ulf de Faire; Anders Hamsten
Remnant lipoproteins are related to intima-media thickness of the carotid artery independently of LDL cholesterol and plasma triglycerides.
Journal of lipid research 2001;42(1):17-21.
2000: Lars H Lindholm; Lennart Hansson; Tord Ekbom; Björn Dahlöf; Jan Lanke; Erland Linjer; Bengt Scherstén; PO Wester; Thomas Hedner; Ulf de Faire
Comparison of antihypertensive treatments in preventing cardiovascular events in elderly diabetic patients: results from the Swedish Trial in Old Patients with Hypertension-2. STOP Hypertension-2 Study Group.
Journal of hypertension 2000;18(11):1671-5.
2000: Sverre E Kjeldsen; Björn Dahlöf; R B Devereux; Stevo Julius; Ulf de Faire; Frej Fyhrquist; Hans Ibsen; Krister Kristianson; Ole Lederballe-Pedersen; Lars H Lindholm; Markku S Nieminen; Per Omvik; Suzanne Oparil; Hans Wedel
Lowering of blood pressure and predictors of response in patients with left ventricular hypertrophy: the LIFE study. Losartan Intervention For Endpoint.
American journal of hypertension 2000;13(8):899-906.
2000: A Graham Pockley; Ruihua Wu; Carola Lemne; Rolf Kiessling; Ulf de Faire; Johan Frostegård
Circulating heat shock protein 60 is associated with early cardiovascular disease.
Hypertension 2000;36(2):303-7.
2000: Lennart Hansson; Thomas Hedner; Per Lund-Johansen; Sverre E Kjeldsen; Lars H Lindholm; Jan Otto Syvertsen; Jan Lanke; Ulf de Faire; Björn Dahlöf; Bengt E Karlberg
Randomised trial of effects of calcium antagonists compared with diuretics and beta-blockers on cardiovascular morbidity and mortality in hypertension: the Nordic Diltiazem (NORDIL) study.
Lancet 2000;356(9227):359-65.
2000: Giacomo Ruotolo; Peter Båvenholm; K Brismar; S Eféndic; Carl-Göran Ericsson; Ulf de Faire; J Nilsson; Anders Hamsten
Serum insulin-like growth factor-I level is independently associated with coronary artery disease progression in young male survivors of myocardial infarction: beneficial effects of bezafibrate treatment.
Journal of the American College of Cardiology 2000;35(3):647-54.
2000: Johan Hallqvist; Jette Möller; Anders Ahlbom; Finn Diderichsen; Christina Reuterwall; Ulf de Faire
Does heavy physical exertion trigger myocardial infarction? A case-crossover analysis nested in a population-based case-referent study.
American journal of epidemiology 2000;151(5):459-67.
1999: Lennart Hansson; Lars H Lindholm; Tord Ekbom; Björn Dahlöf; Jan Lanke; Bengt Scherstén; PO Wester; Thomas Hedner; Ulf de Faire
Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study.
Lancet 1999;354(9192):1751-6.
1999: Ruihua Wu; Carola Lemne; Ulf de Faire; J Frostegârd
Antibodies to platelet-activating factor are associated with borderline hypertension, early atherosclerosis and the metabolic syndrome.
Journal of internal medicine 1999;246(4):389-97.
1999: Camilla Skoglund-Andersson; Rong Tang; M Gene Bond; Ulf de Faire; Anders Hamsten; Fredrik Karpe
LDL particle size distribution is associated with carotid intima-media thickness in healthy 50-year-old men.
Arteriosclerosis, thrombosis, and vascular biology 1999;19(10):2422-30.
1999: Susanna Boquist; Giacomo Ruotolo; Rong Tang; Johan Björkegren; M Gene Bond; Ulf de Faire; Fredrik Karpe; Anders Hamsten
Alimentary lipemia, postprandial triglyceride-rich lipoproteins, and common carotid intima-media thickness in healthy, middle-aged men.
Circulation 1999;100(7):723-8.
1999: Marjan Boerma; L Forsberg; L Van Zeijl; Ralf Morgenstern; Ulf de Faire; Carola Lemne; D Erlinge; Thomas Thulin; Y Hong; Ian A Cotgreave
A genetic polymorphism in connexin 37 as a prognostic marker for atherosclerotic plaque development.
Journal of internal medicine 1999;246(2):211-8.
1999: Christina Reuterwall; Johan Hallqvist; Anders Ahlbom; Ulf de Faire; Finn Diderichsen; Christer Hogstedt; G Pershagen; T Theorell; Björn Wiman; Alicja Wolk
Higher relative, but lower absolute risks of myocardial infarction in women than in men: analysis of some major risk factors in the SHEEP study. The SHEEP Study Group.
Journal of internal medicine 1999;246(2):161-74.
1999: Mai-Lis Hellénius; Jan Johansson; Ulf de Faire; Stig Elofsson; Ingvar Krakau
Four years experience of a cardiovascular opportunistic screening and prevention programme in the primary health care in Sollentuna, Sweden.
Scandinavian journal of primary health care 1999;17(2):111-5.
1999: Lennart Hansson; Lars H Lindholm; Leo Niskanen; Jan Lanke; Thomas Hedner; Anders Niklason; K Luomanmäki; Björn Dahlöf; Ulf de Faire; C Mörlin; Bengt E Karlberg; PO Wester; J E Björck
Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial.
Lancet 1999;353(9153):611-6.
1999: Ruihua Wu; Ulf de Faire; Carola Lemne; J L Witztum; Johan Frostegård
Autoantibodies to OxLDL are decreased in individuals with borderline hypertension.
Hypertension 1999;33(1):53-9.
1998: Fredrik Karpe; Ulf de Faire; M Mercuri; M G Bond; Mai-Lis B Hellénius; Anders Hamsten
Magnitude of alimentary lipemia is related to intima-media thickness of the common carotid artery in middle-aged men.
Atherosclerosis 1998;141(2):307-14.
1998: Björn Dahlöf; Richard B Devereux; Stevo Julius; Sverre E Kjeldsen; Gareth Beevers; Ulf de Faire; Frej Fyhrquist; Thomas Hedner; Hans Ibsen; Krister Kristianson; Ole Lederballe-Pedersen; Lars H Lindholm; Markku S Nieminen; Per Omvik; Suzanne Oparil; Hans Wedel
Characteristics of 9194 patients with left ventricular hypertrophy: the LIFE study. Losartan Intervention For Endpoint Reduction in Hypertension.
Hypertension 1998;32(6):989-97.
1998: Giacomo Ruotolo; Carl-Göran Ericsson; C Tettamanti; Fredrik Karpe; Lars Grip; Bertil Svane; J Nilsson; Ulf de Faire; Anders Hamsten
Treatment effects on serum lipoprotein lipids, apolipoproteins and low density lipoprotein particle size and relationships of lipoprotein variables to progression of coronary artery disease in the Bezafibrate Coronary Atherosclerosis Intervention Trial (BECAIT).
Journal of the American College of Cardiology 1998;32(6):1648-56.
1998: C Lemme; K Lindvall; Ulf de Faire
Changes in cardiac diastolic dimensions precede hypertrophy in early stages of hypertension.
Journal of human hypertension 1998;12(10):679-83.
1998: G Bolinder; Ulf de Faire
Ambulatory 24-h blood pressure monitoring in healthy, middle-aged smokeless tobacco users, smokers, and nontobacco users.
American journal of hypertension 1998;11(10):1153-63.
1998: Johan Frostegård; Ruihua Wu; C Gillis-Haegerstrand; Carola Lemne; Ulf de Faire
Antibodies to endothelial cells in borderline hypertension.
Circulation 1998;98(11):1092-8.
1998: Peter Båvenholm; Ulf de Faire; C Landou; Suad Efendic; J Nilsson; B Wiman; Anders Hamsten
Progression of coronary artery disease in young male post-infarction patients is linked to disturbances of carbohydrate and lipoprotein metabolism and to impaired fibrinolytic function.
European heart journal 1998;19(3):402-10.
1998: Jan Regnström; Stefan Jovinge; Peter Båvenholm; Carl-Göran Ericsson; Ulf de Faire; Anders Hamsten; M L Hellenius; Jan Nilsson; Per Tornvall
Helicobacter pylori seropositivity is not associated with inflammatory parameters, lipid concentrations and degree of coronary artery disease.
Journal of internal medicine 1998;243(2):109-13.
1998: Stefan Jovinge; Anders Hamsten; Per Tornvall; A Proudler; Peter Båvenholm; Carl-Göran Ericsson; I Godsland; Ulf de Faire; Jan Nilsson
Evidence for a role of tumor necrosis factor alpha in disturbances of triglyceride and glucose metabolism predisposing to coronary heart disease.
Metabolism: clinical and experimental 1998;47(1):113-8.
1997: Lennart Hansson; Thomas Hedner; L Lindholm; Anders Niklason; K Luomanmäki; Leo Niskanen; Jan Lanke; Björn Dahlöf; Ulf de Faire; C Mörlin; Bengt E Karlberg; PO Wester; J E Björck
The Captopril Prevention Project (CAPPP) in hypertension--baseline data and current status.
Blood pressure 1997;6(6):365-7.
1997: Anastasia Georgiades; Carola Lemne; Ulf de Faire; K Lindvall; Mats Fredrikson
Stress-induced blood pressure measurements predict left ventricular mass over three years among borderline hypertensive men.
European journal of clinical investigation 1997;27(9):733-9.
1997: G Bolinder; A Norén; Ulf de Faire; J Wahren
Smokeless tobacco use and atherosclerosis: an ultrasonographic investigation of carotid intima media thickness in healthy middle-aged men.
Atherosclerosis 1997;132(1):95-103.
1997: Björn Dahlöf; R Devereux; Ulf de Faire; Frej Fyhrquist; Thomas Hedner; Hans Ibsen; Stevo Julius; Sverre E Kjeldsen; Krister Kristianson; Ole Lederballe-Pedersen; Lars H Lindholm; Markku S Nieminen; Per Omvik; Suzanne Oparil; Hans Wedel
The Losartan Intervention For Endpoint reduction (LIFE) in Hypertension study: rationale, design, and methods. The LIFE Study Group.
American journal of hypertension 1997;10(7 Pt 1):705-13.
1997: Ulf de Faire; Carl-Göran Ericsson; Lars Grip; J Nilsson; Bertil Svane; Anders Hamsten
Retardation of coronary atherosclerosis: the Bezafibrate Coronary Atherosclerosis Intervention Trial (BECAIT) and other angiographic trials.
Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy 1997;11 Suppl 1():257-63.
1997: G Bolinder; A Norén; J Wahren; Ulf de Faire
Long-term use of smokeless tobacco and physical performance in middle-aged men.
European journal of clinical investigation 1997;27(5):427-33.
1997: S Rudberg; C Lemne; B Persson; A Krekula; Ulf de Faire; Anita Aperia
The dopaminuric response to high salt diet in insulin-dependent diabetes mellitus and in family history of hypertension.
Pediatric nephrology (Berlin, Germany) 1997;11(2):169-73.
1997: Johan Frostegård; Carola Lemne; B Andersson; R van der Zee; Rolf Kiessling; Ulf de Faire
Association of serum antibodies to heat-shock protein 65 with borderline hypertension.
Hypertension 1997;29(1 Pt 1):40-4.
1997: Y Hong; N L Pedersen; K Brismar; Ulf de Faire
Genetic and environmental architecture of the features of the insulin-resistance syndrome.
American journal of human genetics 1997;60(1):143-52.
1996: Ulf de Faire; Carl-Göran Ericsson; Lars Grip; J Nilsson; Bertil Svane; Anders Hamsten
Secondary preventive potential of lipid-lowering drugs. The Bezafibrate Coronary Atherosclerosis Intervention Trial (BECAIT).
European heart journal 1996;17 Suppl F():37-42.
1996: A Georgiades; Carola Lemne; Ulf de Faire; K Lindvall; Mats Fredrikson
Stress-induced laboratory blood pressure in relation to ambulatory blood pressure and left ventricular mass among borderline hypertensive and normotensive individuals.
Hypertension 1996;28(4):641-6.
1996: L H Lindholm; L Hansson; Björn Dahlöf; T Ekbom; T Hedner; Ulf de Faire; B Scherstén; PO Wester
The Swedish Trial in old patients with hypertension-2 (STOP-hypertension-2): a progress report.
Blood pressure 1996;5(5):300-4.
1996: Per Tornvall; Peter Båvenholm; Mai-Lis B Hellénius; Fredrik Karpe; Jan Regnström; Ulf de Faire
A decrease in cardiovascular risk factors in healthy 40-year-old Swedish men between 1980-1983 and 1991-1992.
Journal of cardiovascular risk 1996;3(4):379-83.
1996: Carola Lemne; Ulf de Faire
Elevation of plasminogen activator inhibitor 1 in borderline hypertension is linked to concomitant metabolic disturbances.
European journal of clinical investigation 1996;26(8):692-7.
1996: Carl-Göran Ericsson; Anders Hamsten; J Nilsson; Lars Grip; Bertil Svane; Ulf de Faire
Angiographic assessment of effects of bezafibrate on progression of coronary artery disease in young male postinfarction patients.
Lancet 1996;347(9005):849-53.
1995: S Nityanand; Claes C G Bergmark; Ulf de Faire; Jesper Swedenborg; G Holm; Ann Kari Lefvert
Antibodies against endothelial cells and cardiolipin in young patients with peripheral atherosclerotic disease.
Journal of internal medicine 1995;238(5):437-43.
1995: Y Hong; G H Dahlén; N Pedersen; D A Heller; Gerald E McClearn; Ulf de Faire
Potential environmental effects on adult lipoprotein(a) levels: results from Swedish twins.
Atherosclerosis 1995;117(2):295-304.
1995: Peter Båvenholm; A Proudler; Per Tornvall; I Godsland; C Landou; Ulf de Faire; Anders Hamsten
Insulin, intact and split proinsulin, and coronary artery disease in young men.
Circulation 1995;92(6):1422-9.
1995: M L Hellénius; K E Brismar; B H Berglund; Ulf de Faire
Effects on glucose tolerance, insulin secretion, insulin-like growth factor 1 and its binding protein, IGFBP-1, in a randomized controlled diet and exercise study in healthy, middle-aged men.
Journal of internal medicine 1995;238(2):121-30.
1995: Carola Lemne; K Lindvall; A Georgiades; Mats Fredrikson; Ulf de Faire
Structural cardiac changes in relation to 24-h ambulatory blood pressure levels in borderline hypertension.
Journal of internal medicine 1995;238(1):49-57.
1995: Claes C G Bergmark; R Wu; Ulf de Faire; Ann Kari Lefvert; Jesper Swedenborg
Patients with early-onset peripheral vascular disease have increased levels of autoantibodies against oxidized LDL.
Arteriosclerosis, thrombosis, and vascular biology 1995;15(4):441-5.
1995: Peter Båvenholm; A Proudler; Angela Silveira; D Crook; Margareta Blombäck; Ulf de Faire; Anders Hamsten
Relationships of insulin and intact and split proinsulin to haemostatic function in young men with and without coronary artery disease.
Thrombosis and haemostasis 1995;73(4):568-75.
1995: Carola Lemne; T Jogestrand; Ulf de Faire
Carotid intima-media thickness and plaque in borderline hypertension.
Stroke; a journal of cerebral circulation 1995;26(1):34-9.
1995: Ulf de Faire; Carl-Göran Ericsson; Anders Hamsten; J Nilsson
Design features of a five-year Bezafibrate Coronary Atherosclerosis Intervention Trial (BECAIT).
Drugs under experimental and clinical research 1995;21(3):105-24.
1994: Y Hong; Ulf de Faire; D A Heller; Gerald E McClearn; N Pedersen
Genetic and environmental influences on blood pressure in elderly twins.
Hypertension 1994;24(6):663-70.
1994: D A Heller; Nancy L Pedersen; Ulf de Faire; Gerald E McClearn
Genetic and environmental correlations among serum lipids and apolipoproteins in elderly twins reared together and apart.
American journal of human genetics 1994;55(6):1255-67.
1994: Carola Lemne; A Hamsten; F Karpe; P Nilsson-Ehle; Ulf de Faire
Dyslipoproteinemic changes in borderline hypertension.
Hypertension 1994;24(5):605-10.
1994: C Lemne; S Efendic; A Hamsten; Ulf de Faire
Impaired glucose and insulin metabolism in borderline hypertension.
Blood pressure 1994;3(5):287-94.
1994: Carola Lemne; T Lundeberg; E Theodorsson; Ulf de Faire
Increased basal concentrations of plasma endothelin in borderline hypertension.
Journal of hypertension 1994;12(9):1069-74.
1994: G Bolinder; L Alfredsson; A Englund; Ulf de Faire
Smokeless tobacco use and increased cardiovascular mortality among Swedish construction workers.
American journal of public health 1994;84(3):399-404.
1993: Per Tornvall; Peter Båvenholm; C Landou; Ulf de Faire; Anders Hamsten
Relation of plasma levels and composition of apolipoprotein B-containing lipoproteins to angiographically defined coronary artery disease in young patients with myocardial infarction.
Circulation 1993;88(5 Pt 1):2180-9.
1993: Carl-Göran Ericsson; Anders Hamsten; C Landou; L Mesko; R Müller-Suur; J Nilsson; Ulf de Faire
Coronary angiographic changes during 2 years after myocardial infarction largely undetected by repeated tomographic thallium-201 scintigraphy and not reflected by clinical symptoms.
European heart journal 1993;14(7):891-7.
1993: Claes C G Bergmark; M A Mansoor; Jesper Swedenborg; Ulf de Faire; A M Svardal; Per Magne Ueland
Hyperhomocysteinemia in patients operated for lower extremity ischaemia below the age of 50--effect of smoking and extent of disease.
European journal of vascular surgery 1993;7(4):391-6.
1993: Carola Lemne; S Volk-Jovinge; J Nilsson; O Vesterqvist; Ulf de Faire
Plasma growth factor activity and cardiac wall thickness.
Journal of internal medicine 1993;234(1):9-15.
1993: Björn Dahlöf; L Hansson; L H Lindholm; B Scherstén; PO Wester; T Ekbom; Thomas Hedner; Ulf de Faire
STOP-Hypertension 2: a prospective intervention trial of "newer" versus "older" treatment alternatives in old patients with hypertension. Swedish Trial in Old Patients with Hypertension.
Blood pressure 1993;2(2):136-41.
1993: D A Heller; Ulf de Faire; Nancy L Pedersen; G Dahlén; Gerald E McClearn
Genetic and environmental influences on serum lipid levels in twins.
The New England journal of medicine 1993;328(16):1150-6.
1993: Ulf de Faire; K Lindvall; B Nilsson
Noninvasive ambulatory 24 h blood pressures and basal blood pressures predict development of sustained hypertension from a borderline state.
American journal of hypertension 1993;6(2):149-55.
1992: J Nilsson; S Volk-Jovinge; J Svensson; C Landou; Ulf de Faire; Anders Hamsten
Association between high levels of growth factors in plasma and progression of coronary atherosclerosis.
Journal of internal medicine 1992;232(5):397-404.
1992: Carola Lemne; O Vesterqvist; N Egberg; K Green; T Jogestrand; Ulf de Faire
Platelet activation and prostacyclin release in essential hypertension.
Prostaglandins 1992;44(3):219-35.
1992: Carola Lemne; T Jogestrand; Ulf de Faire
Non-invasive assessment of vessel-wall changes in hypertensives and normotensive controls.
Clinical physiology (Oxford, England) 1992;12(4):497-502.
1992: Carl-Göran Ericsson; L Erhardt; Anders Hamsten; L Mesko; A Szamosi; S Zetterquist; Ulf de Faire
Does diffuse coronary atherosclerosis affect the relation between coronary stenoses and uptake of thallium-201 after exercise?
Clinical physiology (Oxford, England) 1992;12(4):475-85.
1992: Magnus von Arbin; M Britton; Ulf de Faire
Mortality and recurrences during eight years following stroke.
Journal of internal medicine 1992;231(1):43-8.
1991: Ulf de Faire; Björn Dahlöf; I Enström; L Hansson; T Hedner; Jan Lanke; L Lindholm; O Samuelsson; A Schwan; T Thulin
[Ambulatory blood pressure measurement--guidelines for registration and data processing].
Läkartidningen 1991;88(50):4352-5.
1987: Anders Hamsten; L Iselius; Ulf de Faire; M Blombäck
Genetic and cultural inheritance of plasma fibrinogen concentration.
Lancet 1987;2(8566):988-91.
1987: Anders Hamsten; Ulf de Faire; G Walldius; G Dahlén; A Szamosi; C Landou; M Blombäck; B Wiman
Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction.
Lancet 1987;2(8549):3-9.
1986: Anders Hamsten; G Walldius; A Szamosi; G Dahlen; Ulf de Faire
Relationship of angiographically defined coronary artery disease to serum lipoproteins and apolipoproteins in young survivors of myocardial infarction.
Circulation 1986;73(6):1097-110.
1984: K Lindvall; Anders Hamsten; C Landou; A Szamosi; Ulf de Faire
Comparative study of echo- and angiocardiographically determined regional left ventricular wall motion in recent myocardial infarction.
European heart journal 1984;5(7):533-44.
1982: Magnus von Arbin; M Britton; Ulf de Faire; C Helmers; K Miah; V Murray
Myocardial infarction in patients with acute cerebrovascular disease.
European heart journal 1982;3(2):136-41.
1981: Magnus von Arbin; M Britton; Ulf de Faire; C Helmers; K Miah; V Murray
Accuracy of bedside diagnosis in stroke.
Stroke; a journal of cerebral circulation 1981;12(3):288-93.